iRhythm Technologies, Inc.
iRhythm Technologies, Inc. (IRTC) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for iRhythm Technologies, Inc. (IRTC), featuring income statements, balance sheets, and cash flow data.
iRhythm Technologies, Inc. (IRTC) Income Statement & Financial Overview
Explore comprehensive income reports for iRhythm Technologies, Inc. IRTC, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $158.68M | $164.32M | $147.54M | $148.05M |
| Cost of Revenue | $49.46M | $49.26M | $46.06M | $44.58M |
| Gross Profit | $109.22M | $115.07M | $101.48M | $103.47M |
| Gross Profit Ratio | $0.69 | $0.70 | $0.69 | $0.70 |
| R&D Expenses | $21.52M | $19.38M | $15.69M | $19.69M |
| SG&A Expenses | $119.96M | $99.77M | $103.38M | $106.76M |
| Operating Expenses | $141.48M | $119.15M | $119.07M | $126.45M |
| Total Costs & Expenses | $190.94M | $168.11M | $165.13M | $171.03M |
| Interest Income | $4.92M | $5.74M | $6.46M | $6.38M |
| Interest Expense | -$3.27M | $3.32M | $3.33M | $3.31M |
| Depreciation & Amortization | $752000.00 | $6.60M | $6.40M | $6.40M |
| EBITDA | -$32.56M | $8.74M | -$36.27M | -$10.20M |
| EBITDA Ratio | -$0.21 | $0.05 | -$0.25 | -$0.07 |
| Operating Income | -$32.56M | -$4.08M | -$50.30M | -$22.98M |
| Operating Income Ratio | -$0.21 | -$0.02 | -$0.34 | -$0.16 |
| Other Income/Expenses (Net) | $2.52M | $2.90M | $4.31M | $3.07M |
| Income Before Tax | -$30.04M | -$1.18M | -$45.99M | -$19.91M |
| Income Before Tax Ratio | -$0.19 | -$0.007 | -$0.31 | -$0.13 |
| Income Tax Expense | $665000.00 | $151000.00 | $188000.00 | $194000.00 |
| Net Income | -$30.70M | -$1.33M | -$46.18M | -$20.11M |
| Net Income Ratio | -$0.19 | -$0.008 | -$0.31 | -$0.14 |
| EPS | -$0.97 | -$0.04 | -$1.48 | -$0.65 |
| Diluted EPS | -$0.97 | -$0.04 | -$1.48 | -$0.65 |
| Weighted Avg Shares Outstanding | $31.59M | $31.34M | $31.26M | $31.14M |
| Weighted Avg Shares Outstanding (Diluted) | $31.59M | $31.34M | $31.26M | $31.14M |
Financial performance has remained strong, with revenue growing from $148.05M in Q2 2024 to $158.68M in Q1 2025. Gross profit continued to perform well, with margins at 69% in the latest quarter. Operating income reached -$32.56M in Q1 2025, holding a steady -21% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$32.56M. Net income dropped to -$30.70M, keeping EPS at -$0.97. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan